Company Filing History:
Years Active: 2017
Title: Fraser J Wilkes: Innovator in Viral Vector Technology
Introduction
Fraser J Wilkes is a notable inventor based in Oxford, GB. He has made significant contributions to the field of biotechnology, particularly in the development of viral vector technologies. His innovative work has led to advancements that are crucial for various applications in gene therapy and molecular biology.
Latest Patents
Fraser J Wilkes holds a patent for a multicistronic retroviral vector genome. This invention features a first nucleic acid sequence upstream of at least one internal regulatory element. The design increases the level of genomic RNA available for packaging in the absence of rev, or a functional equivalent thereof. This patent represents a significant step forward in the efficiency of viral vector systems.
Career Highlights
Wilkes is currently associated with Oxford Biomedica (UK) Limited, a company known for its pioneering work in gene and cell therapy. His role at the company allows him to apply his expertise in viral vector technology to real-world challenges in medicine and research.
Collaborations
Throughout his career, Fraser has collaborated with esteemed colleagues, including Philippa Radcliffe and James Miskin. These partnerships have fostered an environment of innovation and have contributed to the success of various projects within the field.
Conclusion
Fraser J Wilkes is a distinguished inventor whose work in viral vector technology has the potential to transform therapeutic approaches in medicine. His contributions continue to influence the landscape of biotechnology and gene therapy.